Teva rises 15.7% in early trading, Milne jumps 17% – global markets

0
3
Facebook
Twitter
Pinterest
Linkedin
ReddIt
Tumblr
Telegram
Mix
VK
Digg
LINE


Bottle of medicine, photo: Istock

Trump claimed last night that the FDA instructed to check whether hydroxychloroquine (hydroxychloroquine), which is commonly used to treat malaria, may be effective for corona virus infections.Reference: TEVA(Report)Reference: MYL), This is a significant opportunity.

Teva announced yesterday that it will immediately donate 6 million hydrochlorochloroquine tablets to patients across the United States to meet the urgent demand for the drug. The company said it will deliver more than 10 million tablets by the end of the month.

At the same time, Mylan announced that it has started manufacturing hydroxyclorochlorine sulfate tablets at its facility in West Virginia to meet a requirement related to the Corona virus. The company is also taking steps to manufacture the drug outside of the US.

The shares of the two companies jump in early trading up 17% in the background for recent events. For Teva, this is particularly good news, as the company’s bonds for 2021 have risen to more than 10% in recent days as investors feared the company’s ability to meet its debt.

Comments on the article(1):

Your response has been received and posted subject to system policy.
Thanks.

For a new response

Your response was not sent due to a communication problem, please try again.

Return to the comment

  • 1.

    They will already be given to everyone in the country as a preventative. Why do they not understand? (To)

    Shmulik

    20/03/2020
                                    13:56

    1

    0

LEAVE A REPLY

Please enter your comment!
Please enter your name here